West Pharmaceutical Services | WST - Gross Profit On Sales

Stock Price
304.41
Daily Change
1.52 0.50%
Monthly
9.50%
Yearly
40.14%
Q2 Forecast
296.80

West Pharmaceutical Services reported $296.4M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Align Technology USD 736.59M 53M Mar/2026
Avanos Medical USD 94.2M 8.2M Mar/2026
Baxter International USD 891M 314M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Cooper Companies USD 695.2M 44.4M Dec/2025
Dentsply International USD 427M 16M Mar/2026
Haemonetics USD 202.39M 7.64M Dec/2025
ICU Medical USD 202.98M 2.1M Dec/2025
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
J&J USD 17.24B 642M Mar/2026
Medtronic USD 5.41B 27M Dec/2025
Merit Medical Systems USD 184.8M 10.56M Mar/2026
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quidel USD -91.8M 366.6M Mar/2026
Repligen USD 108.28M 4.45M Mar/2026
Rockwell Medical USD 4.55M 1.49M Jun/2024
Solventum Corp USD 1.1B 70M Mar/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Terumo JPY 149.02B 4.17B Mar/2026
Utah Medical Products USD 5.8M 450K Sep/2024
West Pharmaceutical Services USD 296.4M 7.5M Mar/2026